BOSTON, Aug. 28, 2019 /PRNewswire/ -- Seven Bridges, the industry-leading bioinformatics solution provider, today announced that Brian Castagna will join the company as Chief Information Security Officer.

CAMBRIDGE, Mass., Aug. 28, 2019 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy,  today announced its participation in the following upcoming investor conferences:Baird 2019 Global Healthcare Conference i

KFAR SABA, Israel, Aug. 28, 2019 /PRNewswire/ -- An Israeli-based food-tech developer of cannabis-based edibles targeting a variety of different, new and revolutionary types of cannabis infused food, beverages, spices and more, announces today the USA launch of its new brand, "The Pelicann™" to lead Cannibble's lin

SALT LAKE CITY, Aug. 28, 2019 /PRNewswire/ -- PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the H.C. Wainwright 21st Annual Healthcare Conference on September 9, 2019 in Ne

BOTHELL, Wash., Aug. 28, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduct

HOUSTON, Aug. 28, 2019 /PRNewswire/ -- Rescued Pets Movement Inc., the largest homeless animal rehabilitation and transport nonprofit in the United States, today announced its Fur Ball Gala 2019 that will honor Julie and Brook Brookshire with the inaugural Leslie L. Alexander Lifesaving Award.&nb

COLLEYVILLE, Texas, Aug. 28, 2019 /PRNewswire/ -- Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first FDA (510k) cleared magnesium-based bone void filler in the orthopedic marketplace, designed to assist with bone repair and regenera

SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- Parks Associates hosted the sixth annual Connected Health Summit: Independent L

SANFORD, N.C., Aug. 28, 2019 /PRNewswire/ -- DisposeRx, the at-home medication disposal solution, released a statement today regarding the Environmental Protection Agency's (EPA's) final rule for hazardou

JERUSALEM, Aug. 28, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced the appointment of a new Chairman of the Board of Directors and financial results for the quarter ended June 30,